HIGHLIGHTS
- who: Amit Kumar Rai from the (UNIVERSITY) have published the article: Efficacy and safety of Ayush-64 as standalone or adjunct to standard care in COVID-19: a structured summary of protocol for a systematic review, in the Journal: (JOURNAL)
SUMMARY
And safety in disease conditions like influenza-like illness. Government of India recommended the use of AYUSH64 to manage the asymptomatic and mild COVID-19 cases on the basis of outcomes of clinical studies on AYUSH-64 in COVID-19. In this context, this systematic review is planned to synthesize evidence related . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.